Product Overview
Secukinumab | T9930 | TargetMol Chemicals
CAS: 875356-43-7
Smiles:
Formula: N/A
Pathway: Immunology/Inflammation
Target: IL Receptor
Receptor: N/A
Bioactivity: Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Molecular Weight: 151000